Literature DB >> 15823435

Metabolic implications of obesity: before and after gastric bypass.

Donald W Richardson1, Aaron I Vinik.   

Abstract

Obesity is recognized as an inherited disease state, and attributes of modern civilization have enhanced its phenotypic penetrance greatly. Two thirds or more of obese persons suffer comorbidities,many of which are characteristic of (dys)metabolic syndrome of insulin resistance. Unfortunately patients with body mass index over 35 infrequently can achieve or maintain weight loss adequate to resolve these metabolic (and anatomic) issues by lifestyle or pharmacologic strategies and are served better by gastric bypass, in spite of its attendant risks, both surgical and nutritional. This article evaluates the metabolic consequences of obesity and highlights which of these are amenable to correction with weight reduction achieved by gastric bypass.

Entities:  

Mesh:

Year:  2005        PMID: 15823435     DOI: 10.1016/j.gtc.2004.12.009

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  5 in total

1.  Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2.

Authors:  Nicola Scopinaro; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Gianfranco Adami
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

2.  Excess body mass index loss predicts metabolic syndrome remission after gastric bypass.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Mariana Santos; Tiago Morais; Cláudia Freitas; Mariana P Monteiro
Journal:  Diabetol Metab Syndr       Date:  2014-01-02       Impact factor: 3.320

Review 3.  Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance.

Authors:  Bao Q Lam; Rashmi Srivastava; Jason Morvant; Sharmila Shankar; Rakesh K Srivastava
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

4.  Morbid obesity-the new pandemic: medical and surgical management, and implications for the practicing gastroenterologist.

Authors:  John P Cello; Stanley J Rogers
Journal:  Clin Transl Gastroenterol       Date:  2013-06-06       Impact factor: 4.488

5.  Remodeling intestinal flora with sleeve gastrectomy in diabetic rats.

Authors:  Xiaofei Huang; Pan Weng; Huixin Zhang; Yingli Lu
Journal:  J Diabetes Res       Date:  2014-08-04       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.